Assignee
PHOENIX BIOTECHNOLOGY INC
US·25 granted patents·7 pending applications·237 citations·filing 2005–2024
Top patents by PatentIndex Score
32 records- 0198US10729735B1Method and compostitions for treating coronavirus infectionPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted Aug 4, 2020·26 cites·27 claims
- 0295US9358293B2Method of treating neurological conditions with oleandrinPHOENIX BIOTECHNOLOGY INC·Filed 2013·Granted Jun 7, 2016·25 cites·37 claims
- 0395US9220778B2Method of treating neurological conditions with oleandrin-containing extractPHOENIX BIOTECHNOLOGY INC·Filed 2013·Granted Dec 29, 2015·25 cites·28 claims
- 0494US9877979B2Method of treating neurological conditions with oleandrinPHOENIX BIOTECHNOLOGY INC·Filed 2016·Granted Jan 30, 2018·13 cites·25 claims
- 0593US10226497B2Composition for and method of treating neurological conditionsPHOENIX BIOTECHNOLOGY INC·Filed 2017·Granted Mar 12, 2019·10 cites·13 claims
- 0693US9494589B2Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycosidePHOENIX BIOTECHNOLOGY INC·Filed 2015·Granted Nov 15, 2016·15 cites·44 claims
- 0792US10307450B2Method of treating neurological conditions with extract of Nerium species or Thevetia speciesPHOENIX BIOTECHNOLOGY INC·Filed 2017·Granted Jun 4, 2019·4 cites·18 claims
- 0892US8367363B2Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycosidePHOENIX BIOTECHNOLOGY INC·Filed 2010·Granted Feb 5, 2013·20 cites·54 claims
- 0988US7402325B2Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleanderPHOENIX BIOTECHNOLOGY INC·Filed 2005·Granted Jul 22, 2008·82 cites·19 claims
- 1086US11123387B2Method and compositions for treating viral infectionPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted Sep 21, 2021·1 cites·11 claims
- 1186US11013776B2Method and compositions for treating viral infectionPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted May 25, 2021·1 cites·18 claims
- 1285US11007239B2Method and compositions for treating viral infectionPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted May 18, 2021·1 cites·26 claims
- 1385US10980852B2Method and compositions for treating viral infectionPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted Apr 20, 2021·1 cites·29 claims
- 1485US10874704B2Method and compositions for treating viral infectionPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted Dec 29, 2020·1 cites·21 claims
- 1585US10596186B2Method and compositions for treating viral infectionsPHOENIX BIOTECHNOLOGY INC·Filed 2019·Granted Mar 24, 2020·4 cites·33 claims
- 1683US10702567B2Method and compositions for treating viral infectionPHOENIX BIOTECHNOLOGY INC·Filed 2019·Granted Jul 7, 2020·1 cites·20 claims
- 1783US9846156B2Method of treatment employing cardiac glycosidePHOENIX BIOTECHNOLOGY INC·Filed 2016·Granted Dec 19, 2017·3 cites·29 claims
- 1880US11324789B2Method and compositions for treating equine encephalitisPHOENIX BIOTECHNOLOGY INC·Filed 2021·Granted May 10, 2022·0 cites·23 claims
- 1980US10973785B2Method of and improved composition for treating triterpene-responsive conditions, diseases or disordersPHOENIX BIOTECHNOLOGY INC·Filed 2020·Granted Apr 13, 2021·1 cites·14 claims
- 2080US10383886B2Method of treating neurological conditions with oleandrinPHOENIX BIOTECHNOLOGY INC·Filed 2017·Granted Aug 20, 2019·1 cites·32 claims
- 2177US10722482B2Method of and improved composition for treating triterpene-responsive conditions, diseases or disordersPHOENIX BIOTECHNOLOGY INC·Filed 2018·Granted Jul 28, 2020·2 cites·15 claims
- 2270US12097234B2Extract containing oleandrin and method of production thereofPHOENIX BIOTECHNOLOGY INC·Filed 2022·Granted Sep 24, 2024·0 cites·29 claims
- 2370US10960037B2Method of treating neurological conditions with extract of Nerium species or Thevetia speciesPHOENIX BIOTECHNOLOGY INC·Filed 2019·Granted Mar 30, 2021·0 cites·23 claims
- 2468US2024261312A1Method and compositions for treating animal viral infectionsPHOENIX BIOTECHNOLOGY INC·Filed 2024·Application pending·0 cites
- 2567US11806359B2Method and compositions for treating Coronavirus infectionPHOENIX BIOTECHNOLOGY INC·Filed 2021·Granted Nov 7, 2023·0 cites·13 claims
- 2660US2022362275A1Method and Compositions for Treating GlioblastomaPHOENIX BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 2759US2022047616A1Method and Compositions for Treating HTLV-1 Virus InfectionPHOENIX BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2858US2013324485A1Method of Determining the Probability of a Therapeutic Response in Cancer Chemotherapy with Cardiac GlycosidePHOENIX BIOTECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 2958US2022054521A1Method and Compositions for Treating Coronavirus InfectionPHOENIX BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 3051US11331291B2Method of and improved composition for treating triterpene-responsive conditions, diseases or disordersPHOENIX BIOTECHNOLOGY INC·Filed 2021·Granted May 17, 2022·0 cites·13 claims
- 3147US2015283191A1Method of Treating Neurological Conditions with Extract of Nerium Species or Thevetia SpeciesPHOENIX BIOTECHNOLOGY INC·Filed 2015·Application pending·0 cites
- 3244US2006188536A1Particles from processing of oleander leavesPHOENIX BIOTECHNOLOGY INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PHOENIX BIOTECHNOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →